Literature DB >> 21412836

Ventricular enlargement and mild cognitive impairment in early Parkinson's disease.

Turi O Dalaker1, Robert Zivadinov, Deepa Preeti Ramasamy, Mona K Beyer, Guido Alves, Kolbjorn S Bronnick, Ole-Bjorn Tysnes, Dag Aarsland, Jan P Larsen.   

Abstract

Mild cognitive impairment (MCI) may predict future development of dementia in Parkinson's disease (PD). We aimed to examine the extent of subcortical brain atrophy in patients with early PD with and without MCI compared to normal controls (NC). Participating in a population-based study were 43 early, drug-naïve PD patients and 41 NC. Eleven patients were classified with MCI (MCI PD) and 32 patients without (non-MCI PD). Volumetric segmentation of 3D-T1 weighted brain MRI was performed using FreeSurfer. Groups were compared applying MANCOVA corrected for total intracranial volume, age, and sex. Results showed that left inferior lateral ventricle and third ventricle volumes were significantly larger in MCI PD than in non-MCI PD and NC. Fourth ventricular size in MCI PD was significantly different from NC and highly correlated with memory performance in MCI PD patients. This suggests that cognitive dysfunction in early PD may be associated with ventricular enlargement.
Copyright © 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 21412836     DOI: 10.1002/mds.23443

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

2.  Regional gray matter atrophy in patients with Parkinson disease and freezing of gait.

Authors:  A Tessitore; M Amboni; G Cirillo; D Corbo; M Picillo; A Russo; C Vitale; G Santangelo; R Erro; M Cirillo; F Esposito; P Barone; G Tedeschi
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

3.  Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment.

Authors:  Liana Apostolova; Guido Alves; Kristy S Hwang; Sona Babakchanian; Kolbjorn S Bronnick; Jan Petter Larsen; Paul M Thompson; Yi-Yu Chou; Ole B Tysnes; Hege K Vefring; Mona K Beyer
Journal:  Neurobiol Aging       Date:  2011-08-03       Impact factor: 4.673

4.  MTA index: a simple 2D-method for assessing atrophy of the medial temporal lobe using clinically available neuroimaging.

Authors:  Manuel Menéndez-González; Alfonso López-Muñiz; José A Vega; José M Salas-Pacheco; Oscar Arias-Carrión
Journal:  Front Aging Neurosci       Date:  2014-03-24       Impact factor: 5.750

5.  Mice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations.

Authors:  Heidi O Nousiainen; Ileana B Quintero; Timo T Myöhänen; Vootele Voikar; Jelena Mijatovic; Mikael Segerstråle; Annakaisa M Herrala; Natalia Kulesskaya; Anitta E Pulkka; Tanja Kivinummi; Usama Abo-Ramadan; Tomi Taira; T Petteri Piepponen; Heikki Rauvala; Pirkko Vihko
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

6.  Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.

Authors:  Lars Tatenhorst; Katrin Eckermann; Vivian Dambeck; Luis Fonseca-Ornelas; Hagen Walle; Tomás Lopes da Fonseca; Jan C Koch; Stefan Becker; Lars Tönges; Mathias Bähr; Tiago F Outeiro; Markus Zweckstetter; Paul Lingor
Journal:  Acta Neuropathol Commun       Date:  2016-04-22       Impact factor: 7.801

7.  Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson's Disease.

Authors:  Niels J H M Gerrits; Anita C van Loenhoud; Stan F van den Berg; Henk W Berendse; Elisabeth M J Foncke; Martin Klein; Diederick Stoffers; Ysbrand D van der Werf; Odile A van den Heuvel
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

8.  Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study.

Authors:  Angela E P Bouwmans; Albert F G Leentjens; Werner H Mess; Wim E J Weber
Journal:  Parkinsons Dis       Date:  2016-01-10

9.  A comparison of FreeSurfer-generated data with and without manual intervention.

Authors:  Christopher S McCarthy; Avinash Ramprashad; Carlie Thompson; Jo-Anna Botti; Ioana L Coman; Wendy R Kates
Journal:  Front Neurosci       Date:  2015-10-21       Impact factor: 4.677

10.  Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.

Authors:  Elijah Mak; Li Su; Guy B Williams; Michael J Firbank; Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Brit Mollenhauer; Adrian M Owen; Tien K Khoo; David J Brooks; James B Rowe; Roger A Barker; David J Burn; John T O'Brien
Journal:  Neurobiol Aging       Date:  2017-03-16       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.